Variability in commercial histoplasma complement fixation antigens.

AUTOR(ES)

Leland, D S

RESUMO

Using Immuno-Mycologics (IMMY; Norman, Okla.) histoplasmal yeast (HY) and mycelial (HM) antibody complement fixation test antigens, we retested 1,386 samples that were initially tested with Meridian Diagnostics, Inc. (Cincinnati, Ohio), antigens. Histoplasma antibody was identified (greater than or equal to 1:16) in 20% of HY and 5% of HM samples reported to have titers of less than 1:8 with Meridian reagents. IMMY titers were at least fourfold higher than Meridian titers in 39% of HY and 54% of HM samples that initially had titers of greater than or equal to 1:8 with Meridian antigens. Because 30 of 58 (52%) samples from confirmed cases of histoplasmosis yielded negative results with Meridian antigens and positive results upon retesting with IMMY antigens, we concluded that the Meridian antigens had less reactivity with human histoplasmal antibody.

Documentos Relacionados

• Variation in complement fixation test results with three Histoplasma capsulatum yeast phase antigens.
• Difference in antibody reactivity between complement fixation and immune adherence hemagglutination tests with virus antigens.
• Single radial complement fixation test for assaying antibody to influenza virus type-specific antigens.
• EVALUATION OF HISTOPLASMIN AND YEAST PHASE ANTIGENS DERIVED FROM A SINGLE STRAIN OF HISTOPLASMA CAPSULATUM IN THE COMPLEMENT FIXATION TEST
• Production and characterization of murine monoclonal antibodies to Histoplasma capsulatum yeast cell antigens.